Mill Creek Capital Advisors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,103
| Closed | -$28.1K | – | 256 |
|
|
2024
Q2 | $28.1K | Sell |
2,103
-52
| -2% | -$695 | ﹤0.01% | 258 |
|
|
2024
Q1 | $100K | Buy |
2,155
+52
| +2% | +$2.41K | ﹤0.01% | 238 |
|
|
2023
Q4 | $142K | Hold |
2,103
| – | – | ﹤0.01% | 234 |
|
|
2023
Q3 | $152K | Sell |
2,103
-25
| -1% | -$1.81K | 0.01% | 219 |
|
|
2023
Q2 | $158K | Buy |
2,128
+25
| +1% | +$1.86K | 0.01% | 232 |
|
|
2023
Q1 | $112K | Sell |
2,103
-7
| -0.3% | -$372 | ﹤0.01% | 239 |
|
|
2022
Q4 | $143K | Buy |
+2,110
| New | +$143K | 0.01% | 219 |
|